Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Vicore Pharma Holding AB

Closing information (x1000 SEK)

Closing information 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 476 More Arrow 2,563 Less Arrow 6
Earnings before taxes -288,806 Less Arrow -296,735 More Arrow -147,315
EBITDA -287,368 Less Arrow -291,220
Total assets 338,007 More Arrow 451,168 Less Arrow 406,515
Current assets 269,790 More Arrow 377,931 Less Arrow 327,847
Current liabilities 46,292 More Arrow 65,570 Less Arrow 44,294
Equity capital 289,083 More Arrow 383,316 Less Arrow 354,513
- share capital 40,924 Less Arrow 35,880 Less Arrow 25,087
Employees (average) 21 Less Arrow 16 Less Arrow 13

Financial ratios

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 85.5% Less Arrow 85.0% More Arrow 87.2%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -85.3% More Arrow -65.2% More Arrow -36.2%
Current ratio 582.8% Less Arrow 576.4% More Arrow 740.2%
Return on equity (ROE) -99.9% More Arrow -77.4% More Arrow -41.6%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 5 Less Arrow 3 More Arrow 5
Chg. No. of employees % 31% Less Arrow 23% More Arrow 63%

Total value of public sale

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.